US5439686A
(en)
*
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
US6245805B1
(en)
*
|
1995-10-26 |
2001-06-12 |
Baker Norton Pharmaceuticals, Inc. |
Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
|
US6964946B1
(en)
*
|
1995-10-26 |
2005-11-15 |
Baker Norton Pharmaceuticals, Inc. |
Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
|
US20070092563A1
(en)
*
|
1996-10-01 |
2007-04-26 |
Abraxis Bioscience, Inc. |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
US20030105156A1
(en)
*
|
1997-01-07 |
2003-06-05 |
Nagesh Palepu |
Method for administration of a taxane/tocopherol formulation to enhance taxane therapeutic utility
|
US20030087954A1
(en)
*
|
1997-01-07 |
2003-05-08 |
Sonus Pharmaceuticals, Inc. |
Method of treating bladder carcinoma using a Taxane/Tocopherol formulation
|
US6727280B2
(en)
|
1997-01-07 |
2004-04-27 |
Sonus Pharmaceuticals, Inc. |
Method for treating colorectal carcinoma using a taxane/tocopherol formulation
|
US6458373B1
(en)
*
|
1997-01-07 |
2002-10-01 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
US8853260B2
(en)
|
1997-06-27 |
2014-10-07 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
GB9715759D0
(en)
*
|
1997-07-26 |
1997-10-01 |
Danbiosyst Uk |
New emulsion formulations
|
IL131217A0
(en)
*
|
1998-03-10 |
2001-01-28 |
Napro Biotherapeutics Inc |
Novel methods and compositions for delivery of taxanes
|
US20030059465A1
(en)
*
|
1998-05-11 |
2003-03-27 |
Unger Evan C. |
Stabilized nanoparticle formulations of camptotheca derivatives
|
US7030155B2
(en)
*
|
1998-06-05 |
2006-04-18 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
US6241969B1
(en)
*
|
1998-06-26 |
2001-06-05 |
Elan Corporation Plc |
Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
|
US6174547B1
(en)
*
|
1999-07-14 |
2001-01-16 |
Alza Corporation |
Dosage form comprising liquid formulation
|
US8236352B2
(en)
|
1998-10-01 |
2012-08-07 |
Alkermes Pharma Ireland Limited |
Glipizide compositions
|
US20040013613A1
(en)
*
|
2001-05-18 |
2004-01-22 |
Jain Rajeev A |
Rapidly disintegrating solid oral dosage form
|
US8293277B2
(en)
*
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
CA2346001C
(fr)
*
|
1998-10-01 |
2003-12-30 |
Elan Pharma International, Limited |
Liberation regulee de compositions nanoparticulaires
|
US7521068B2
(en)
*
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
US6428814B1
(en)
*
|
1999-10-08 |
2002-08-06 |
Elan Pharma International Ltd. |
Bioadhesive nanoparticulate compositions having cationic surface stabilizers
|
US6071952A
(en)
*
|
1998-12-02 |
2000-06-06 |
Mylan Pharmaceuticals, Inc. |
Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
|
IL143580A0
(en)
*
|
1998-12-11 |
2002-04-21 |
Pharmasolutions Inc |
Pharmaceutical compositions containing lipophilic drugs and methods for the preparation thereof
|
US6632443B2
(en)
|
2000-02-23 |
2003-10-14 |
National Research Council Of Canada |
Water-soluble compositions of bioactive lipophilic compounds
|
US20080070981A1
(en)
|
2000-02-23 |
2008-03-20 |
Henryk Borowy-Borowski |
Water-soluble compositions of bioactive lipophilic compounds
|
US6045826A
(en)
*
|
1999-04-02 |
2000-04-04 |
National Research Council Of Canada |
Water-soluble compositions of bioactive lipophilic compounds
|
CA2366884A1
(fr)
*
|
1999-04-02 |
2000-10-12 |
Washington State University Research Foundation |
Administration amelioree de composes de vitamine e au niveau tissulaire et infracellulaire
|
CA2369587C
(fr)
*
|
1999-04-13 |
2009-12-22 |
Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) |
Composition pharmaceutique solubilisee a administration parenterale
|
JP2003500368A
(ja)
*
|
1999-05-24 |
2003-01-07 |
ソーナス ファーマシューティカルス,インコーポレイテッド |
溶解度が不十分な薬剤のためのエマルジョンビヒクル
|
KR100754352B1
(ko)
*
|
1999-05-24 |
2007-08-31 |
소너스파머슈티칼즈인코포레이티드 |
난용성 약물용 에멀젼 부형제의 제조방법
|
EP1479382A1
(fr)
*
|
1999-06-18 |
2004-11-24 |
IVAX Research, Inc. |
Compositions pharmaceutiques orales contenant des taxanes et méthodes de traitement dans lesquelles lesdites compositions sont utilisées
|
US20090104273A1
(en)
*
|
1999-06-22 |
2009-04-23 |
Elan Pharma International Ltd. |
Novel nifedipine compositions
|
US6982281B1
(en)
|
2000-11-17 |
2006-01-03 |
Lipocine Inc |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
US20030236236A1
(en)
*
|
1999-06-30 |
2003-12-25 |
Feng-Jing Chen |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
CA2385989A1
(fr)
|
1999-09-27 |
2001-04-05 |
Andrew Nienstedt |
Compositions de composes therapeutiques solubles dans le tocol
|
US6828346B2
(en)
*
|
1999-10-25 |
2004-12-07 |
Supergen, Inc. |
Methods for administration of paclitaxel
|
US6136846A
(en)
*
|
1999-10-25 |
2000-10-24 |
Supergen, Inc. |
Formulation for paclitaxel
|
FR2803203B1
(fr)
*
|
1999-12-31 |
2002-05-10 |
Fournier Ind & Sante |
Nouvelles formulations galeniques du fenofibrate
|
US20040009229A1
(en)
*
|
2000-01-05 |
2004-01-15 |
Unger Evan Charles |
Stabilized nanoparticle formulations of camptotheca derivatives
|
DE60111352T2
(de)
*
|
2000-01-20 |
2006-05-04 |
Supratek Pharma, Inc., Montreal |
Podophyllotoxin-zusammensetzungen
|
US6589968B2
(en)
|
2001-02-13 |
2003-07-08 |
Kosan Biosciences, Inc. |
Epothilone compounds and methods for making and using the same
|
US8618085B2
(en)
*
|
2000-04-28 |
2013-12-31 |
Koasn Biosciences Incorporated |
Therapeutic formulations of desoxyepothilones
|
US20040156872A1
(en)
*
|
2000-05-18 |
2004-08-12 |
Elan Pharma International Ltd. |
Novel nimesulide compositions
|
GB0016876D0
(en)
*
|
2000-07-11 |
2000-08-30 |
Astrazeneca Ab |
Novel formulation
|
ES2238050T3
(es)
*
|
2000-07-24 |
2005-08-16 |
PHARMACIA & UPJOHN COMPANY LLC |
Sistemas emulsionantes de liberacion de farmacos para farmacos lipofilos extremadamente insolubles en agua.
|
US7198795B2
(en)
|
2000-09-21 |
2007-04-03 |
Elan Pharma International Ltd. |
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
|
AU2001293177A1
(en)
*
|
2000-09-27 |
2002-04-08 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
AUPR549901A0
(en)
|
2001-06-06 |
2001-07-12 |
Vital Health Sciences Pty Ltd |
Topical formulation containing tocopheryl phosphates
|
CA2426885C
(fr)
*
|
2000-11-14 |
2010-06-29 |
Vital Health Sciences Pty Ltd |
Complexes de derives de phosphate
|
EP1609468A3
(fr)
*
|
2000-11-22 |
2006-01-25 |
Rxkinetix, Inc. |
Une composition sur la base d'un antioxydant contenant du soufre et son utilisation pour la production d'un médicament pour le traitement de la mucosite
|
WO2002043765A2
(fr)
*
|
2000-11-28 |
2002-06-06 |
Transform Pharmaceuticals, Inc. |
Formulations pharmaceutiques contenant du paclitaxel, ses derives et ses sels pharmaceutiquement acceptables
|
CA2428993C
(fr)
*
|
2000-11-29 |
2011-05-31 |
Lyotropic Therapeutics, Inc. |
Systemes de solvants pour agents pharmaceutiques
|
DK1349545T3
(da)
*
|
2000-12-05 |
2009-02-16 |
Los Angeles Childrens Hospital |
Farmaceutiske præparater af fenretinid med öget biotilgængelighed samt fremgangsmåder til anvendelse deraf
|
IN188917B
(fr)
*
|
2000-12-07 |
2002-11-23 |
Bharat Surums & Vaccines Ltd |
|
US8067032B2
(en)
*
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
US20030072807A1
(en)
*
|
2000-12-22 |
2003-04-17 |
Wong Joseph Chung-Tak |
Solid particulate antifungal compositions for pharmaceutical use
|
US20040022862A1
(en)
*
|
2000-12-22 |
2004-02-05 |
Kipp James E. |
Method for preparing small particles
|
US20030096013A1
(en)
*
|
2000-12-22 |
2003-05-22 |
Jane Werling |
Preparation of submicron sized particles with polymorph control
|
US20050048126A1
(en)
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
US9700866B2
(en)
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
US7193084B2
(en)
*
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
US6977085B2
(en)
*
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
US7115565B2
(en)
*
|
2001-01-18 |
2006-10-03 |
Pharmacia & Upjohn Company |
Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
|
US6893859B2
(en)
|
2001-02-13 |
2005-05-17 |
Kosan Biosciences, Inc. |
Epothilone derivatives and methods for making and using the same
|
CN1547475B
(zh)
|
2001-07-27 |
2010-12-15 |
生命健康科学有限公司 |
含电子转移试剂的磷酸酯衍生物的皮肤制剂
|
AUPR684801A0
(en)
*
|
2001-08-06 |
2001-08-30 |
Vital Health Sciences Pty Ltd |
Supplement therapy
|
US20030099674A1
(en)
*
|
2001-08-11 |
2003-05-29 |
Chen Andrew X. |
Lyophilized injectable formulations containing paclitaxel or other taxoid drugs
|
US20030054042A1
(en)
*
|
2001-09-14 |
2003-03-20 |
Elaine Liversidge |
Stabilization of chemical compounds using nanoparticulate formulations
|
JP2005504090A
(ja)
|
2001-09-26 |
2005-02-10 |
バクスター・インターナショナル・インコーポレイテッド |
分散体および溶媒相または液相の除去によるサブミクロンサイズ−ナノ粒子の調製
|
US6858227B1
(en)
|
2001-11-21 |
2005-02-22 |
Sonus Pharmaceuticals, Inc. |
Vitamin E conjugates
|
US20040092428A1
(en)
*
|
2001-11-27 |
2004-05-13 |
Hongming Chen |
Oral pharmaceuticals formulation comprising paclitaxel, derivatives and methods of administration thereof
|
IL162213A0
(en)
*
|
2001-12-03 |
2005-11-20 |
Novacea Inc |
Pharmaceutical compositions containing active vitamin d compounds
|
AU2002353118A1
(en)
*
|
2001-12-11 |
2003-07-24 |
Dor Biopharma, Inc. |
Lipid particles and suspensions and uses thereof
|
EP1460995B1
(fr)
*
|
2001-12-13 |
2010-11-10 |
Vital Health Sciences Pty Ltd. |
Transport transdermique de composes
|
DE60332212D1
(de)
|
2002-02-04 |
2010-06-02 |
Elan Pharma Int Ltd |
Arzneistoffnanopartikel mit lysozym-oberflächenstabilisator
|
US6683194B2
(en)
*
|
2002-02-05 |
2004-01-27 |
Sonus Pharmaceuticals, Inc. |
Tocopherol derivatives
|
US7635463B2
(en)
*
|
2002-02-27 |
2009-12-22 |
Pharmain Corporation |
Compositions for delivery of therapeutics and other materials
|
US20050260259A1
(en)
*
|
2004-04-23 |
2005-11-24 |
Bolotin Elijah M |
Compositions for treatment with glucagon-like peptide, and methods of making and using the same
|
US7138105B2
(en)
*
|
2002-02-27 |
2006-11-21 |
Pharmain |
Compositions for delivery of therapeutics and other materials, and methods of making and using the same
|
EP1340497A1
(fr)
*
|
2002-03-01 |
2003-09-03 |
Novagali Sas |
Systèmes d'apport de médicament auto-émulsifiant pour médicaments à faible solubilité
|
ATE359779T1
(de)
*
|
2002-03-01 |
2007-05-15 |
Novagali Pharma Sa |
Selbstemulgierende systeme zur abgabe von taxoiden
|
US20080004332A1
(en)
*
|
2002-03-07 |
2008-01-03 |
Alkon Daniel L |
Methods for alzheimer's disease treatment and cognitive enhancement
|
US6825229B2
(en)
|
2002-03-07 |
2004-11-30 |
Blanchette Rockefeller Neurosciences Institute |
Methods for Alzheimer's Disease treatment and cognitive enhancement
|
US20050065205A1
(en)
*
|
2002-03-07 |
2005-03-24 |
Daniel Alkon |
Methods for Alzheimer's disease treatment and cognitive enhance
|
EP1490030B2
(fr)
*
|
2002-03-20 |
2010-07-14 |
Elan Pharma International Limited |
Compositions nanoparticulaires d'inhibiteurs d'angiogenese
|
US7101576B2
(en)
|
2002-04-12 |
2006-09-05 |
Elan Pharma International Limited |
Nanoparticulate megestrol formulations
|
US20040105889A1
(en)
*
|
2002-12-03 |
2004-06-03 |
Elan Pharma International Limited |
Low viscosity liquid dosage forms
|
DK1509256T3
(da)
|
2002-05-24 |
2009-11-23 |
Angiotech Int Ag |
Præparater og fremgangsmåde til coating af medicinske implantater
|
FR2840614B1
(fr)
*
|
2002-06-07 |
2004-08-27 |
Flamel Tech Sa |
Polyaminoacides fonctionnalises par de l'alpha-tocopherol et leurs applications notamment therapeutiques
|
EP1551457A1
(fr)
*
|
2002-07-16 |
2005-07-13 |
Elan Pharma International Limited |
Compositions pour doses liquides d'agents actifs nanoparticulaires stables
|
KR101131794B1
(ko)
*
|
2002-07-30 |
2012-03-30 |
와이어쓰 엘엘씨 |
Cci-779 공용매 농축액, 비경구 cci-779 제형 및 비경구 cci-779 제형의 제조방법
|
AU2002950713A0
(en)
|
2002-08-09 |
2002-09-12 |
Vital Health Sciences Pty Ltd |
Carrier
|
US7718189B2
(en)
|
2002-10-29 |
2010-05-18 |
Transave, Inc. |
Sustained release of antiinfectives
|
PT1562941E
(pt)
|
2002-11-07 |
2010-01-25 |
Kosan Biosciences Inc |
Trans-9,10-desidroepotilona c e d, seus análogos e métodos de fabrico dos mesmos
|
KR100507771B1
(ko)
*
|
2002-11-08 |
2005-08-17 |
한미약품 주식회사 |
난용성 감기약 활성 성분의 경구투여용 조성물 및 그의제조 방법
|
US20050026877A1
(en)
*
|
2002-12-03 |
2005-02-03 |
Novacea, Inc. |
Pharmaceutical compositions comprising active vitamin D compounds
|
AU2003299590B8
(en)
|
2002-12-09 |
2010-04-08 |
Abraxis Bioscience, Llc |
Compositions and methods of delivery of pharmacological agents
|
US20040115287A1
(en)
*
|
2002-12-17 |
2004-06-17 |
Lipocine, Inc. |
Hydrophobic active agent compositions and methods
|
KR100502821B1
(ko)
|
2002-12-26 |
2005-07-22 |
이호영 |
구리산화물 또는 구리 나노와이어로 이루어진 전자방출팁의 저온 형성 방법 및 이 방법에 의해 제조된 전자방출팁을 포함하는 디스플레이 장치 또는 광원
|
US7824709B2
(en)
|
2003-02-14 |
2010-11-02 |
Children's Hospital And Research Center At Oakland |
Lipophilic drug delivery vehicle and methods of use thereof
|
US20050196370A1
(en)
*
|
2003-03-18 |
2005-09-08 |
Zhi-Jian Yu |
Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye
|
US20060251685A1
(en)
*
|
2003-03-18 |
2006-11-09 |
Zhi-Jian Yu |
Stable ophthalmic oil-in-water emulsions with Omega-3 fatty acids for alleviating dry eye
|
US20040185068A1
(en)
*
|
2003-03-18 |
2004-09-23 |
Zhi-Jian Yu |
Self-emulsifying compositions, methods of use and preparation
|
WO2004091506A2
(fr)
*
|
2003-04-10 |
2004-10-28 |
Ivax Research, Inc. |
Compositions a base de taxane et procedes d'utilisation
|
US7485671B2
(en)
|
2003-05-16 |
2009-02-03 |
Velocys, Inc. |
Process for forming an emulsion using microchannel process technology
|
CA2526965C
(fr)
*
|
2003-05-16 |
2011-10-11 |
Velocys Inc. |
Procede pour former une emulsion par la technique de traitement en microcanal
|
US7691838B2
(en)
|
2003-05-30 |
2010-04-06 |
Kosan Biosciences Incorporated |
Method for treating diseases using HSP90-inhibiting agents in combination with antimitotics
|
US20050020546A1
(en)
*
|
2003-06-11 |
2005-01-27 |
Novacea, Inc. |
Pharmaceutical compositions comprising active vitamin D compounds
|
US20060189586A1
(en)
*
|
2003-06-11 |
2006-08-24 |
Cleland Jeffrey L |
Pharmaceutical compositions comprising active vitamin D compounds
|
EP1498120A1
(fr)
*
|
2003-07-18 |
2005-01-19 |
Aventis Pharma S.A. |
Formulation semi-solide pour l'administration orale du taxol
|
DE602004014624D1
(de)
*
|
2003-08-29 |
2008-08-07 |
Yissum Res Dev Co |
Selbst-nanoemulgierende ölige formulierung zur verabreichung von schwer wasserlöslichen arzneimitteln
|
EP1510206A1
(fr)
*
|
2003-08-29 |
2005-03-02 |
Novagali Pharma SA |
Formulation huileuse auto-émulsifiable pour l'administration de principes actifs peu solubles dans l'eau
|
US20050107465A1
(en)
*
|
2003-10-01 |
2005-05-19 |
Papas Andreas M. |
Composition for treating inflammatory bowel disease
|
US20050074446A1
(en)
*
|
2003-10-01 |
2005-04-07 |
Papas Andreas M. |
Gamma-tocopherol treatment for cystic fibrosis
|
CN100471886C
(zh)
*
|
2003-10-10 |
2009-03-25 |
株式会社三养社 |
两亲嵌段共聚物以及包含它的用于给药的聚合组合物
|
CA2523987C
(fr)
*
|
2003-10-10 |
2009-08-04 |
Samyang Corporation |
Copolymere sequence amphiphile et composition polymere comprenant celui-ci pour l'administration de medicaments
|
US7311901B2
(en)
*
|
2003-10-10 |
2007-12-25 |
Samyang Corporation |
Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery
|
DE10347994A1
(de)
*
|
2003-10-15 |
2005-06-16 |
Pari GmbH Spezialisten für effektive Inhalation |
Wässrige Aerosol-Zubereitung
|
US20080045559A1
(en)
*
|
2003-10-29 |
2008-02-21 |
Sonus Pharmaceuticals, Inc. |
Tocopherol-modified therapeutic drug compounds
|
AU2004285037B2
(en)
*
|
2003-10-29 |
2010-07-22 |
Sonus Pharmaceuticals, Inc. |
Tocopherol-modified therapeutic drug compounds
|
US20050096365A1
(en)
*
|
2003-11-03 |
2005-05-05 |
David Fikstad |
Pharmaceutical compositions with synchronized solubilizer release
|
US20060003002A1
(en)
*
|
2003-11-03 |
2006-01-05 |
Lipocine, Inc. |
Pharmaceutical compositions with synchronized solubilizer release
|
TWI350183B
(en)
*
|
2003-12-31 |
2011-10-11 |
Ind Tech Res Inst |
A liposome and a preparation method
|
US20050158329A1
(en)
*
|
2004-01-21 |
2005-07-21 |
Ghosh Swapan K. |
Novel phytol derived immunoadjuvants and their use in vaccine formulations
|
US20060281716A1
(en)
*
|
2004-03-03 |
2006-12-14 |
West Simon M |
Alkaloid formulations
|
US20050209315A1
(en)
*
|
2004-03-20 |
2005-09-22 |
Papas Andreas M |
Bioavailable nutritional supplement and method of treatment of malabsorption
|
US7989490B2
(en)
*
|
2004-06-02 |
2011-08-02 |
Cordis Corporation |
Injectable formulations of taxanes for cad treatment
|
US8003122B2
(en)
*
|
2004-03-31 |
2011-08-23 |
Cordis Corporation |
Device for local and/or regional delivery employing liquid formulations of therapeutic agents
|
US20050220866A1
(en)
*
|
2004-04-02 |
2005-10-06 |
Dr. Reddy's Laboratories Limited |
Novel capsule formulations of etoposide for oral use
|
KR20050099311A
(ko)
*
|
2004-04-09 |
2005-10-13 |
에이엔에이치 케어연구소(주) |
주사제용 항암제 조성물
|
US20050226932A1
(en)
*
|
2004-04-09 |
2005-10-13 |
Samyang Corporation |
Pharmaceutical formulations for itraconazole
|
TW200538181A
(en)
|
2004-05-18 |
2005-12-01 |
Brni Neurosciences Inst |
Treatment of depressive disorders
|
KR100582604B1
(ko)
|
2004-06-16 |
2006-05-23 |
보람제약주식회사 |
항산화제를 포함한 이부프로펜 및 덱시부프로펜의마이크로 에멀젼과 이를 이용한 투명 액제 및 투명연질캡슐 제제
|
RU2007107359A
(ru)
*
|
2004-07-28 |
2008-09-10 |
ЭсДи ФАРМАСЬЮТИКАЛЗ, ИНК. (US) |
Стабильная инъецируемая композиция альфа-токоферилсукцината, его аналогов и солей
|
NZ553476A
(en)
*
|
2004-08-03 |
2010-06-25 |
Vital Health Sciences Pty Ltd |
Carrier for enteral administration
|
KR100623013B1
(ko)
*
|
2004-09-04 |
2006-09-19 |
김영대 |
나노에멀션, 그의 용도 및 제조방법
|
US8557861B2
(en)
*
|
2004-09-28 |
2013-10-15 |
Mast Therapeutics, Inc. |
Low oil emulsion compositions for delivering taxoids and other insoluble drugs
|
US20060165769A1
(en)
*
|
2004-09-30 |
2006-07-27 |
Hyatt John A |
Pharmaceutical formulations containing vitamin E TPGS molecules that solubilize lipophilic drugs without significant efflux inhibition, and use of such formulations
|
US20080038316A1
(en)
*
|
2004-10-01 |
2008-02-14 |
Wong Vernon G |
Conveniently implantable sustained release drug compositions
|
JP5643474B2
(ja)
*
|
2004-10-01 |
2014-12-17 |
ヴェロシス,インク. |
マイクロチャネルプロセス技術を用いる多相混合プロセス
|
WO2006047579A2
(fr)
*
|
2004-10-26 |
2006-05-04 |
Yasoo Health, Inc. |
Concentre liquide de tpgs a la vitamine e contenant un faible pourcentage d'eau
|
CA2587412C
(fr)
*
|
2004-11-17 |
2013-03-26 |
Velocys Inc. |
Procede pour former une emulsion par la technique de traitement en microcanal
|
GT200500310A
(es)
|
2004-11-19 |
2006-06-19 |
|
Compuestos organicos
|
US20060147518A1
(en)
*
|
2004-12-30 |
2006-07-06 |
Pierre Fabre Medicament |
Stable solid dispersion of a derivative of vinca alkaloid and process for manufacturing it
|
JP4877899B2
(ja)
*
|
2005-01-25 |
2012-02-15 |
学校法人近畿大学 |
薬物徐放出性球状微粒子及びその製造方法
|
US20090239827A1
(en)
*
|
2005-03-03 |
2009-09-24 |
Esra Ogru |
Compounds having lipid lowering properties
|
US20060222716A1
(en)
*
|
2005-04-01 |
2006-10-05 |
Joseph Schwarz |
Colloidal solid lipid vehicle for pharmaceutical use
|
AU2006235538A1
(en)
*
|
2005-04-12 |
2006-10-19 |
Wisconsin Alumni Research Foundation |
Micelle composition of polymer and passenger drug
|
US20060240051A1
(en)
*
|
2005-04-26 |
2006-10-26 |
Singleton Andy H |
Eutectic blends containing a water soluble vitamin derivative
|
MX2007013494A
(es)
|
2005-04-29 |
2008-01-24 |
Kosan Biosciences Inc |
Metodo para tratar mieloma multiple utilizando 17-aag o 17-ag o un profarmaco de ya sea 17-aag o 17-ag.
|
WO2006134864A1
(fr)
*
|
2005-06-13 |
2006-12-21 |
Dainippon Sumitomo Pharma Co., Ltd. |
Preparation d'une solubilisation
|
NZ565049A
(en)
*
|
2005-06-17 |
2012-02-24 |
Vital Health Sciences Pty Ltd |
A carrier comprising one or more DI and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
|
WO2007016202A1
(fr)
|
2005-07-29 |
2007-02-08 |
Blanchette Rockefeller Neurosciences Institute |
Utilisation d'un activateur de pkc seul ou combine a un inhibiteur de pkc pour renforcer la memoire a long terme
|
AU2006280511A1
(en)
*
|
2005-08-12 |
2007-02-22 |
Astrazeneca Ab |
Process
|
EP1760093B1
(fr)
*
|
2005-08-30 |
2011-12-21 |
LANXESS Deutschland GmbH |
Utilisation de catalyseurs pour la dégradation de caoutchouc nitrile par métathèse
|
US20090306198A1
(en)
*
|
2005-09-16 |
2009-12-10 |
Robert Nicolosi |
Anti-Oxidant Synergy Formulation Nanoemulsions to Treat Caner
|
CN101346128B
(zh)
*
|
2005-10-25 |
2013-10-02 |
雅培制药有限公司 |
包含低水溶解度药物的配方及其使用方法
|
WO2007056424A2
(fr)
*
|
2005-11-07 |
2007-05-18 |
Penwest Pharmaceuticals, Co. |
Compositions d'emulsion a liberation controlee
|
US7858609B2
(en)
|
2005-11-28 |
2010-12-28 |
Marinus Pharmaceuticals |
Solid ganaxolone formulations and methods for the making and use thereof
|
EP1965787B1
(fr)
*
|
2005-11-30 |
2013-04-10 |
Endo Pharmaceuticals Inc. |
Traitement de la xerostomie par un agent antioxydant sulfureux
|
US9486408B2
(en)
|
2005-12-01 |
2016-11-08 |
University Of Massachusetts Lowell |
Botulinum nanoemulsions
|
EP3718532A1
(fr)
|
2005-12-08 |
2020-10-07 |
Insmed Incorporated |
Compositions a base de lipide d'anti-infectieux pour traiter des infections pulmonaires
|
KR20150125732A
(ko)
|
2005-12-19 |
2015-11-09 |
파마인 코포레이션 |
치료제를 전달하기 위한 소수성 코어 담체 조성물, 이 조성물의 제조 방법 및 그 조성물의 이용 방법
|
CN101011355B
(zh)
*
|
2006-02-01 |
2013-01-02 |
陈献 |
经维生素e琥珀酸酯稳定的医药组合物、其制备及用途
|
TWI376239B
(en)
*
|
2006-02-01 |
2012-11-11 |
Andrew Xian Chen |
Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
|
ES2330898T3
(es)
*
|
2006-03-10 |
2009-12-16 |
Laboswiss Ag |
Procedimiento para la solubilizacion, dispersion y estabilizacion de sustancias, productos preparados de acuerdo con el procedimiento, asi como su uso.
|
CN101472676B
(zh)
|
2006-04-20 |
2013-09-11 |
万罗赛斯公司 |
利用微通道工艺技术处理和/或形成一种非牛顿流体的方法
|
US8112292B2
(en)
|
2006-04-21 |
2012-02-07 |
Medtronic Navigation, Inc. |
Method and apparatus for optimizing a therapy
|
KR100917809B1
(ko)
|
2006-05-22 |
2009-09-18 |
에스케이케미칼주식회사 |
우수한 저장안정성을 갖는 도세탁셀 함유 주사제 조성물
|
EP2056818B1
(fr)
|
2006-08-11 |
2011-05-25 |
The Johns Hopkins University |
Compositions et méthodes de neuroprotection
|
CN102887900B
(zh)
|
2006-09-22 |
2015-04-29 |
药品循环公司 |
布鲁顿酪氨酸激酶的抑制剂
|
US8660635B2
(en)
|
2006-09-29 |
2014-02-25 |
Medtronic, Inc. |
Method and apparatus for optimizing a computer assisted surgical procedure
|
US8430055B2
(en)
|
2008-08-29 |
2013-04-30 |
Lutonix, Inc. |
Methods and apparatuses for coating balloon catheters
|
US8414525B2
(en)
|
2006-11-20 |
2013-04-09 |
Lutonix, Inc. |
Drug releasing coatings for medical devices
|
US9700704B2
(en)
|
2006-11-20 |
2017-07-11 |
Lutonix, Inc. |
Drug releasing coatings for balloon catheters
|
US9737640B2
(en)
|
2006-11-20 |
2017-08-22 |
Lutonix, Inc. |
Drug releasing coatings for medical devices
|
US8425459B2
(en)
|
2006-11-20 |
2013-04-23 |
Lutonix, Inc. |
Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent
|
US20080175887A1
(en)
|
2006-11-20 |
2008-07-24 |
Lixiao Wang |
Treatment of Asthma and Chronic Obstructive Pulmonary Disease With Anti-proliferate and Anti-inflammatory Drugs
|
US8414526B2
(en)
|
2006-11-20 |
2013-04-09 |
Lutonix, Inc. |
Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids
|
US20080276935A1
(en)
|
2006-11-20 |
2008-11-13 |
Lixiao Wang |
Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs
|
EP2066321A2
(fr)
*
|
2006-11-20 |
2009-06-10 |
Lutonix, Inc. |
Traitement de l'asthme et de la bronchopneumopathie chronique obstructive à l'aide de médicaments antiprolifératifs et anti-inflammatoires
|
US8998846B2
(en)
|
2006-11-20 |
2015-04-07 |
Lutonix, Inc. |
Drug releasing coatings for balloon catheters
|
US8414910B2
(en)
|
2006-11-20 |
2013-04-09 |
Lutonix, Inc. |
Drug releasing coatings for medical devices
|
BRPI0717721A2
(pt)
|
2006-11-28 |
2013-10-29 |
Marinus Pharmaceuticals |
"partículas complexadas de drogas, composição farmacêutica, uso de uma composição farmacêutica, partículas complexadas de droga estabilizadas no tamanho, método para a preparação de partículas estabilizadas da droga, composição farmacêutica sólida, comprimido oral ingerível e composição líquida em nanopartículas estabilizadas no tamanho"
|
AU2007329579A1
(en)
|
2006-12-01 |
2008-06-12 |
Anterios, Inc. |
Amphiphilic entity nanoparticles
|
WO2008088037A1
(fr)
*
|
2007-01-18 |
2008-07-24 |
National University Corporation Chiba University |
Préparation médicinale à particules fines
|
CA2873179A1
(fr)
*
|
2007-02-09 |
2008-08-21 |
Blanchette Rockefeller Neurosciences Institute |
Utilisation de bryostatines et de neristatines pour le traitement de difficulte cognitive attribuable a un traumatisme cranien
|
JP2010517759A
(ja)
*
|
2007-02-09 |
2010-05-27 |
アストラゼネカ・アクチエボラーグ |
水性媒体中における固体非晶質サブミクロン粒子の安定な分散体を製造する方法
|
CN101244053B
(zh)
*
|
2007-02-16 |
2010-12-08 |
石药集团中奇制药技术(石家庄)有限公司 |
以多西他赛为主组分的新的分散体系
|
WO2008106571A2
(fr)
*
|
2007-02-28 |
2008-09-04 |
Abbott Laboratories |
Formulations parentérales de buprénorphine à libération prolongée
|
US20100196455A1
(en)
|
2007-05-04 |
2010-08-05 |
Transave, Inc. |
Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
|
US9119783B2
(en)
|
2007-05-07 |
2015-09-01 |
Insmed Incorporated |
Method of treating pulmonary disorders with liposomal amikacin formulations
|
US9333214B2
(en)
|
2007-05-07 |
2016-05-10 |
Insmed Incorporated |
Method for treating pulmonary disorders with liposomal amikacin formulations
|
US9114081B2
(en)
|
2007-05-07 |
2015-08-25 |
Insmed Incorporated |
Methods of treating pulmonary disorders with liposomal amikacin formulations
|
US8722736B2
(en)
|
2007-05-22 |
2014-05-13 |
Baxter International Inc. |
Multi-dose concentrate esmolol with benzyl alcohol
|
US8426467B2
(en)
|
2007-05-22 |
2013-04-23 |
Baxter International Inc. |
Colored esmolol concentrate
|
MX2009013663A
(es)
*
|
2007-06-22 |
2010-01-27 |
Scidose Llc |
Formulacion solubilizada de docetaxel sin tween 80.
|
US7960336B2
(en)
|
2007-08-03 |
2011-06-14 |
Pharmain Corporation |
Composition for long-acting peptide analogs
|
US8563527B2
(en)
|
2007-08-20 |
2013-10-22 |
Pharmain Corporation |
Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same
|
KR101257550B1
(ko)
|
2007-09-10 |
2013-04-24 |
칼시메디카, 인크 |
세포내 칼슘을 조절하는 화합물
|
AU2008310956B2
(en)
*
|
2007-10-08 |
2014-08-07 |
Aurinia Pharmaceuticals Inc. |
Ophthalmic compositions comprising calcineurin inhibitors or mTOR inhibitors
|
US20090130198A1
(en)
*
|
2007-11-21 |
2009-05-21 |
Innopharmax Inc. |
Pharmaceutical composition with enhanced bioavailability
|
CA2710525C
(fr)
*
|
2007-12-24 |
2017-08-22 |
Sun Pharma Advanced Research Company Limited |
Nanodispersion
|
US20090176892A1
(en)
*
|
2008-01-09 |
2009-07-09 |
Pharmain Corporation |
Soluble Hydrophobic Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same
|
CN101519404B
(zh)
|
2008-02-29 |
2016-01-20 |
唐莉 |
15环噻酮衍生物及其制备方法与应用
|
DE102008015366A1
(de)
*
|
2008-03-20 |
2009-09-24 |
Merck Patent Gmbh |
Lyophilisierte Nanoemulsion
|
CA2715018C
(fr)
*
|
2008-03-20 |
2012-11-13 |
Virun, Inc. |
Derives de la vitamine e et leurs utilisations
|
DK2268160T3
(da)
|
2008-03-20 |
2013-01-07 |
Virun Inc |
Emulsioner omfattende et PEG-derivat af tokoferol
|
WO2009120933A2
(fr)
*
|
2008-03-28 |
2009-10-01 |
Particle Sciences, Inc. |
Solutions pharmaceutiques et procédé pour solubiliser des agents thérapeutiques
|
US8420110B2
(en)
*
|
2008-03-31 |
2013-04-16 |
Cordis Corporation |
Drug coated expandable devices
|
US8409601B2
(en)
|
2008-03-31 |
2013-04-02 |
Cordis Corporation |
Rapamycin coated expandable devices
|
EP2300451A1
(fr)
|
2008-06-02 |
2011-03-30 |
Cedars-Sinai Medical Center |
Promédicaments de dimension nanométrique de nsaids
|
WO2009158678A1
(fr)
|
2008-06-27 |
2009-12-30 |
Children's Hospital & Research Center At Oakland |
Véhicule d'administration d'acide nucléique lipophile et ses procédés d'utilisation
|
WO2010009075A1
(fr)
*
|
2008-07-14 |
2010-01-21 |
The University Of North Carolina At Chapel Hill |
Procédés et compositions comprenant des nanoparticules cristallines de composés hydrophobes
|
FR2933871B1
(fr)
*
|
2008-07-18 |
2012-12-14 |
Yvery |
Formulation destinee a ameliorer la biodisponibilite d'une molecule hydrophobe
|
JP5782377B2
(ja)
|
2008-08-27 |
2015-09-24 |
カルシメディカ,インク. |
細胞内カルシウムを調節する化合物
|
CA2737607A1
(fr)
*
|
2008-09-19 |
2010-03-25 |
Richard Anthony Gibbs |
Carboxy-chromanols a chaines longues et analogues destines a etre utilises comme agents anti-inflammatoires
|
US9676744B2
(en)
|
2008-09-19 |
2017-06-13 |
Purdue Research Foundation |
Long-chain carboxychromanols and analogs for use as anti-inflammatory agents
|
US8165658B2
(en)
*
|
2008-09-26 |
2012-04-24 |
Medtronic, Inc. |
Method and apparatus for positioning a guide relative to a base
|
US20140105822A1
(en)
*
|
2008-11-24 |
2014-04-17 |
Cedars-Sinai Medical Center |
Nanospheres comprising tocopherol, an amphiphilic spacer and a therapeutic or imaging agent
|
US20100158905A1
(en)
|
2008-12-19 |
2010-06-24 |
Nuon Therapeutics, Inc. |
Combination therapy of arthritis with tranilast
|
US11304960B2
(en)
|
2009-01-08 |
2022-04-19 |
Chandrashekar Giliyar |
Steroidal compositions
|
JP5339980B2
(ja)
*
|
2009-03-23 |
2013-11-13 |
富士フイルム株式会社 |
分散組成物及び分散組成物の製造方法
|
CN102458370A
(zh)
*
|
2009-06-09 |
2012-05-16 |
卢克斯生物科技公司 |
用于眼科用途的表面药物递送系统
|
EA201270050A1
(ru)
|
2009-06-19 |
2012-05-30 |
Сан Фарма Адвансед Ресёрч Компани Лтд. |
Нанодисперсия лекарственного средства и способ ее получения
|
CA2775747A1
(fr)
|
2009-10-07 |
2011-04-14 |
Sanford Burnham Medical Research Institute |
Methodes et compositions associees a des composes lipidiques lies au caillot
|
US7741330B1
(en)
|
2009-10-12 |
2010-06-22 |
Pharmacyclics, Inc. |
Pyrazolo-pyrimidine inhibitors of Bruton's tyrosine kinase
|
US20110092579A1
(en)
*
|
2009-10-19 |
2011-04-21 |
Scidose Llc |
Solubilized formulation of docetaxel
|
US8476310B2
(en)
|
2009-10-19 |
2013-07-02 |
Scidose Llc |
Docetaxel formulations with lipoic acid
|
US8541465B2
(en)
*
|
2009-10-19 |
2013-09-24 |
Scidose, Llc |
Docetaxel formulations with lipoic acid and/or dihydrolipoic acid
|
US8912228B2
(en)
|
2009-10-19 |
2014-12-16 |
Scidose Llc |
Docetaxel formulations with lipoic acid
|
US7772274B1
(en)
|
2009-10-19 |
2010-08-10 |
Scidose, Llc |
Docetaxel formulations with lipoic acid
|
CN102101863B
(zh)
|
2009-12-17 |
2014-10-15 |
唐莉 |
新型环氧噻酮化合物及其制备方法和用途
|
WO2012094020A1
(fr)
|
2010-01-07 |
2012-07-12 |
Innopharma, Inc. |
Procédés et compositions pour l'administration de taxanes dans des émulsions huile dans l'eau stables
|
US10071030B2
(en)
|
2010-02-05 |
2018-09-11 |
Phosphagenics Limited |
Carrier comprising non-neutralised tocopheryl phosphate
|
TWI438009B
(zh)
*
|
2010-02-19 |
2014-05-21 |
Teikoku Pharma Usa Inc |
紫杉烷前-乳劑調配物及其製造與使用之方法
|
CN103037708B
(zh)
*
|
2010-03-23 |
2015-05-20 |
维尔恩公司 |
含有蔗糖脂肪酸酯的纳米乳液
|
MX2012010935A
(es)
*
|
2010-03-26 |
2012-12-10 |
Onconova Therapeutics Inc |
Formulacion acuosa estable mejorada de (e)-4-carboxiestiril-4-clor obencil sulfona.
|
CA2794734C
(fr)
|
2010-03-30 |
2017-12-12 |
Phosphagenics Limited |
Timbre transdermique
|
ES2602475T3
(es)
|
2010-04-15 |
2017-02-21 |
Tracon Pharmaceuticals, Inc. |
Potenciación de la actividad anticáncer por terapia de combinación con inhibidores de la vía BER
|
EP2560640A1
(fr)
|
2010-04-19 |
2013-02-27 |
Synta Pharmaceuticals Corp. |
Thérapie anticancéreuse à l'aide d'une combinaison d'un composé inhibiteur de hsp90 et d'un inhibiteur d'egfr
|
US8754219B2
(en)
|
2010-04-27 |
2014-06-17 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
JP6112486B2
(ja)
|
2010-04-27 |
2017-04-12 |
カルシメディカ,インク. |
細胞内カルシウムを調節する化合物
|
CN102970990A
(zh)
|
2010-05-03 |
2013-03-13 |
帝国制药美国公司 |
非水性紫杉烷前-乳剂制剂以及制备和使用该制剂的方法
|
EP2568999B1
(fr)
|
2010-05-11 |
2018-07-11 |
Mallinckrodt Ard Ip Limited |
Acth pour le traitement de la sclérose latérale amyotrophique
|
US20130172333A1
(en)
*
|
2010-05-20 |
2013-07-04 |
Synta Pharmaceuticals Corp. |
Formulation and dosing of hsp90 inhibitory compounds
|
NZ789041A
(en)
|
2010-06-03 |
2023-09-29 |
Pharmacyclics Llc |
The use of inhibitors of bruton’s tyrosine kinase (btk)
|
WO2011162802A1
(fr)
|
2010-06-21 |
2011-12-29 |
Virun, Inc. |
Compositions contenant des composés non polaires
|
CA2809830C
(fr)
|
2010-08-27 |
2019-09-10 |
Calcimedica, Inc. |
Composes renfermant du n-acyl-2-amino-1,3-thiazole servant a moduler le calcium intracellulaire
|
US8796416B1
(en)
|
2010-10-25 |
2014-08-05 |
Questcor Pharmaceuticals, Inc |
ACTH prophylactic treatment of renal disorders
|
US11224659B2
(en)
|
2010-10-29 |
2022-01-18 |
Infirst Healthcare Limited |
Solid solution compositions and use in severe pain
|
US10695432B2
(en)
|
2010-10-29 |
2020-06-30 |
Infirst Healthcare Limited |
Solid solution compositions and use in severe pain
|
US11730709B2
(en)
|
2010-10-29 |
2023-08-22 |
Infirst Healthcare Limited |
Compositions and methods for treating severe pain
|
US8895536B2
(en)
|
2010-10-29 |
2014-11-25 |
Infirst Healthcare Ltd. |
Compositions and methods for treating chronic inflammation and inflammatory diseases
|
US9308213B2
(en)
|
2010-10-29 |
2016-04-12 |
Infirst Healthcare Limited |
Solid solution compositions and use in chronic inflammation
|
US9737500B2
(en)
|
2010-10-29 |
2017-08-22 |
Infirst Healthcare Limited |
Compositions and methods for treating severe pain
|
US10695431B2
(en)
|
2010-10-29 |
2020-06-30 |
Infirst Healthcare Limited |
Solid solution compositions and use in cardiovascular disease
|
US9504664B2
(en)
|
2010-10-29 |
2016-11-29 |
Infirst Healthcare Limited |
Compositions and methods for treating severe pain
|
US9271950B2
(en)
|
2010-10-29 |
2016-03-01 |
Infirst Healthcare Limited |
Compositions for treating chronic inflammation and inflammatory diseases
|
US11202831B2
(en)
|
2010-10-29 |
2021-12-21 |
Infirst Healthcare Limited |
Solid solution compositions and use in cardiovascular disease
|
US9744132B2
(en)
|
2010-10-29 |
2017-08-29 |
Infirst Healthcare Limited |
Solid solution compositions and use in chronic inflammation
|
WO2012063182A1
(fr)
*
|
2010-11-08 |
2012-05-18 |
Cadila Pharmaceuticals Limited |
Composition pharmaceutique de taxoïdes
|
US20180153904A1
(en)
|
2010-11-30 |
2018-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US9034858B2
(en)
|
2010-11-30 |
2015-05-19 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US9358241B2
(en)
|
2010-11-30 |
2016-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US20120148675A1
(en)
|
2010-12-10 |
2012-06-14 |
Basawaraj Chickmath |
Testosterone undecanoate compositions
|
MX346224B
(es)
*
|
2011-02-04 |
2017-03-10 |
Biocopea Ltd |
Composiciones y metodos para el tratamiento de inflamacion cronica y enfermedades inflamatorias.
|
EP2685992A4
(fr)
|
2011-03-15 |
2014-09-10 |
Phosphagenics Ltd |
Amino-quinoléines en tant qu'inhibiteurs de kinase
|
EP2773345A1
(fr)
|
2011-11-02 |
2014-09-10 |
Synta Pharmaceuticals Corp. |
Thérapie anticancéreuse utilisant une combinaison d'inhibiteurs de hsp 90 et d'inhibiteurs de topoisomérase i
|
EP2776025A1
(fr)
|
2011-11-02 |
2014-09-17 |
Synta Pharmaceuticals Corp. |
Polythérapie d'inhibiteurs de hsp 90 avec des agents contenant du platine
|
US9717678B2
(en)
*
|
2011-11-06 |
2017-08-01 |
Murty Pharmaceuticals, Inc. |
Delivery systems for improving oral bioavailability of Fenobam, its hydrates, and salts
|
JP2014533299A
(ja)
|
2011-11-14 |
2014-12-11 |
シンタ ファーマシューティカルズ コーポレーション |
Braf阻害剤とhsp90阻害剤の組合せ療法
|
US8377946B1
(en)
|
2011-12-30 |
2013-02-19 |
Pharmacyclics, Inc. |
Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
|
US10874122B2
(en)
|
2012-02-10 |
2020-12-29 |
Virun, Inc. |
Beverage compositions containing non-polar compounds
|
US20130226550A1
(en)
*
|
2012-02-23 |
2013-08-29 |
Hassan Benameur |
Systems and methods for modeling compound formulations
|
EP2852391B1
(fr)
|
2012-05-21 |
2021-11-17 |
Insmed Incorporated |
Systèmes de traitement d'infections pulmonaires
|
AR091857A1
(es)
|
2012-07-25 |
2015-03-04 |
Sova Pharmaceuticals Inc |
INHIBIDORES DE CISTATIONIN-g-LIASA (CSE)
|
AR091858A1
(es)
|
2012-07-25 |
2015-03-04 |
Sova Pharmaceuticals Inc |
INHIBIDORES DE CISTATIONIN-g-LIASA (CSE)
|
JO3685B1
(ar)
|
2012-10-01 |
2020-08-27 |
Teikoku Pharma Usa Inc |
صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
|
US9512116B2
(en)
|
2012-10-12 |
2016-12-06 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
RU2018135921A
(ru)
|
2012-11-29 |
2019-02-05 |
Инсмед Инкорпорейтед |
Стабилизированные составы ванкомицина
|
ES2643057T3
(es)
*
|
2012-12-21 |
2017-11-21 |
National Health Research Institutes |
Nanopartículas mesóporas de sílice para la absorción de aceite
|
JP6122646B2
(ja)
*
|
2013-01-23 |
2017-04-26 |
昭和電工株式会社 |
皮膚外用剤
|
WO2014153221A2
(fr)
|
2013-03-14 |
2014-09-25 |
Questcor Pharmaceuticals, Inc. |
Acth dans le traitement du syndrome de détresse respiratoire aiguë
|
US9351517B2
(en)
|
2013-03-15 |
2016-05-31 |
Virun, Inc. |
Formulations of water-soluble derivatives of vitamin E and compositions containing same
|
US20140314672A1
(en)
*
|
2013-04-06 |
2014-10-23 |
Igdrasol, Inc. |
Nanoparticle therapeutic agents, their formulations, and methods of their use
|
US11044923B2
(en)
|
2013-06-20 |
2021-06-29 |
Vitasome Labs, Inc. |
Gummies containing formulations with enhanced delivery matrix, and methods of making same
|
US10299492B2
(en)
*
|
2013-06-20 |
2019-05-28 |
James John YIANNIOS |
Dietary supplement compositions with enhanced delivery matrix, gummies, chocolates, atomizers and powders containing same, and methods of making same
|
US9585417B2
(en)
*
|
2013-06-20 |
2017-03-07 |
Vitasome Labs, Inc. |
Dietary supplement compositions with enhanced delivery matrix, and methods of making the same
|
US9693574B2
(en)
|
2013-08-08 |
2017-07-04 |
Virun, Inc. |
Compositions containing water-soluble derivatives of vitamin E mixtures and modified food starch
|
US9896403B2
(en)
*
|
2014-08-22 |
2018-02-20 |
Ironstone Separations, Inc. |
Solubilization of pterostilbene and resveratrol in aqueous beverages
|
WO2015054283A1
(fr)
|
2013-10-08 |
2015-04-16 |
Calcimedica, Inc. |
Composés qui modulent le calcium intracellulaire
|
WO2015084998A1
(fr)
|
2013-12-05 |
2015-06-11 |
Pharmacyclics, Inc. |
Inhibiteurs de la tyrosine kinase de bruton
|
ES2755941T3
(es)
|
2014-05-15 |
2020-04-24 |
Insmed Inc |
Métodos para tratar infecciones pulmonares micobacterianas no tuberculosas
|
WO2016033549A2
(fr)
|
2014-08-28 |
2016-03-03 |
Lipocine Inc. |
Compositions de (17-ss)-3-oxoandrost-4-èn-17-yl tridécanoate et leurs procédés de préparation et d'utilisation
|
WO2016033556A1
(fr)
|
2014-08-28 |
2016-03-03 |
Lipocine Inc. |
Esters de (17-β)-hydroxy-4-androstène-3-one biodisponibles à l'état solide
|
US9839644B2
(en)
|
2014-09-09 |
2017-12-12 |
ARKAY Therapeutics, LLC |
Formulations and methods for treatment of metabolic syndrome
|
US10016363B2
(en)
|
2014-09-18 |
2018-07-10 |
Virun, Inc. |
Pre-spray emulsions and powders containing non-polar compounds
|
US9861611B2
(en)
|
2014-09-18 |
2018-01-09 |
Virun, Inc. |
Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same
|
MY182652A
(en)
*
|
2014-11-25 |
2021-01-27 |
Kl Kepong Oleomas Sdn Bhd |
Formulation for effective tocotrienol delivery
|
US9359316B1
(en)
|
2014-11-25 |
2016-06-07 |
Concentric Analgesics, Inc. |
Prodrugs of phenolic TRPV1 agonists
|
US10227333B2
(en)
|
2015-02-11 |
2019-03-12 |
Curtana Pharmaceuticals, Inc. |
Inhibition of OLIG2 activity
|
WO2016138505A1
(fr)
|
2015-02-27 |
2016-09-01 |
Ebbu, LLC |
Compositions comprenant des combinaisons de cannabinoïdes purifiés, ayant au moins un flavonoïde, terpène ou minéral
|
IL254007B1
(en)
|
2015-02-27 |
2024-04-01 |
Curtana Pharmaceuticals Inc |
Inhibition of OLIG2 activity
|
WO2016154288A1
(fr)
*
|
2015-03-23 |
2016-09-29 |
President And Fellows Of Harvard |
Procédés et compositions pour injecter des solutions d'agent actif à haute concentration et/ou à haute viscosité
|
WO2017040617A1
(fr)
|
2015-08-31 |
2017-03-09 |
Pharmacyclics Llc |
Combinaisons d'inhibiteurs de btk pour le traitement du myélome multiple
|
TWI752750B
(zh)
|
2015-09-30 |
2022-01-11 |
香港商慧源香港創新有限公司 |
口服紫杉烷組合物及方法
|
EP3368543B1
(fr)
|
2015-10-26 |
2020-09-23 |
MAX Biopharma, Inc. |
Oxystérols et signalisation hedgehog
|
US9637514B1
(en)
|
2015-10-26 |
2017-05-02 |
MAX BioPharma, Inc. |
Oxysterols and hedgehog signaling
|
CN114712308A
(zh)
*
|
2015-12-09 |
2022-07-08 |
磷肌酸有限公司 |
药物制剂
|
US20170196802A1
(en)
|
2016-01-08 |
2017-07-13 |
Abon Pharmaceuticals, Llc |
Long Acting Injectable Formulations
|
US10851123B2
(en)
|
2016-02-23 |
2020-12-01 |
Concentric Analgesics, Inc. |
Prodrugs of phenolic TRPV1 agonists
|
JP7049683B2
(ja)
|
2016-04-04 |
2022-04-07 |
シノピア バイオサイエンシーズ,インク. |
トラピジルを使用する錐体外路症候群の処置
|
CA3024556A1
(fr)
|
2016-05-12 |
2017-11-16 |
The Regents Of The University Of Michigan |
Inhibiteurs de ash1l et methodes de traitement au moyen de ceux-ci
|
EP3463576A4
(fr)
|
2016-05-25 |
2020-01-15 |
Concentric Analgesics, Inc. |
Promédicaments à base d'agonistes de trpv1 phénoliques en association avec des anesthésiques locaux et des vasoconstricteurs pour améliorer une anesthésie locale
|
WO2017205769A1
(fr)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibiteurs de la kinase associée au récepteur de l'interleukine 1
|
WO2017205766A1
(fr)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibiteurs de la kinase associée au récepteur de l'interleukine-1
|
WO2017205762A1
(fr)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibiteurs de la kinase associée au récepteur de l'interleukine 1
|
CN109843868A
(zh)
|
2016-08-26 |
2019-06-04 |
科泰纳制药公司 |
Olig2活性的抑制
|
EP3503875A4
(fr)
*
|
2016-08-29 |
2020-06-24 |
Canopy Growth Corporation |
Compositions hydrosolubles comprenant des cannabinoïdes purifiés
|
JP2019535829A
(ja)
|
2016-11-21 |
2019-12-12 |
エイリオン セラピューティクス, インコーポレイテッド |
大型薬剤の経皮送達
|
US20180147215A1
(en)
|
2016-11-28 |
2018-05-31 |
Lipocine Inc. |
Oral testosterone undecanoate therapy
|
AU2017381395A1
(en)
|
2016-12-21 |
2019-06-20 |
Phosphagenics Limited |
Process
|
US11141398B2
(en)
|
2017-01-08 |
2021-10-12 |
The United States Government As Represented By The Department Of Veterans Affairs |
Methods for decreasing injuries associated with intraoperative hypotension
|
US20190224275A1
(en)
|
2017-05-12 |
2019-07-25 |
Aurinia Pharmaceuticals Inc. |
Protocol for treatment of lupus nephritis
|
US11319320B2
(en)
|
2017-11-06 |
2022-05-03 |
Snap Bio, Inc. |
PIM kinase inhibitor compositions, methods, and uses thereof
|
US11110177B2
(en)
|
2017-11-10 |
2021-09-07 |
The Regents Of The University Of Michigan |
ASH1L degraders and methods of treatment therewith
|
EP3720439A4
(fr)
|
2017-12-07 |
2021-09-08 |
The Regents Of The University Of Michigan |
Inhibiteurs de la famille nsd et méthodes de traitement comprenant ces derniers
|
EP3508562A1
(fr)
*
|
2018-01-05 |
2019-07-10 |
Castrol Limited |
Émulsions micellaires
|
US11685722B2
(en)
|
2018-02-28 |
2023-06-27 |
Curtana Pharmaceuticals, Inc. |
Inhibition of Olig2 activity
|
WO2019191627A1
(fr)
|
2018-03-30 |
2019-10-03 |
Insmed Incorporated |
Procédés pour la fabrication continue de produits médicamenteux liposomaux
|
CN112368301A
(zh)
|
2018-04-30 |
2021-02-12 |
西达-赛奈医疗中心 |
用于选择和治疗炎性疾病患者的方法和系统
|
EP3810138A4
(fr)
*
|
2018-05-25 |
2022-03-09 |
RESQ Pharma Inc. |
Émulsions lipidiques et leurs utilisations
|
EP4155293A1
(fr)
|
2018-06-07 |
2023-03-29 |
The Regents of The University of Michigan |
Inhibiteurs de prc1 et méthodes de traitement comprenant ces derniers
|
EP3830078A4
(fr)
|
2018-07-27 |
2022-03-30 |
Concentric Analgesics, Inc. |
Promédicaments pegylés d'agonistes du trpv1 phénolique
|
US20200069742A1
(en)
|
2018-08-29 |
2020-03-05 |
Myos Rens Technology Inc. |
Methods for alleviating, inhibiting or reversing muscle disuse atrophy in mammals
|
TW202027725A
(zh)
*
|
2018-09-25 |
2020-08-01 |
愛爾蘭商托爾瑪國際有限公司 |
供藥物之延長投予之液體聚合物輸送系統
|
US20200108102A1
(en)
|
2018-10-03 |
2020-04-09 |
Myos Rens Technology Inc. |
Spray dried follistatin product
|
WO2020096660A1
(fr)
|
2018-11-06 |
2020-05-14 |
Myos Rens Technology, Inc. |
Procédés et compositions pour améliorer le taux de synthèse fractionnaire de la protéine du muscle squelettique
|
JP2022516057A
(ja)
|
2018-12-31 |
2022-02-24 |
バイオメア フュージョン,エルエルシー |
メニン-mll相互作用の不可逆的阻害剤
|
WO2020160113A1
(fr)
|
2019-02-01 |
2020-08-06 |
Myos Rens Technology Inc. |
Poudre de jaune d'oeuf pour améliorer la qualité de vie et augmenter l'activité chez des mammifères vieillissants et chroniquement malades
|
US20220265630A1
(en)
|
2019-03-15 |
2022-08-25 |
Unicycive Therapeutics Inc. |
Nicorandil derivatives
|
JP2022533956A
(ja)
|
2019-05-14 |
2022-07-27 |
プロメテウス バイオサイエンシーズ,インク. |
Tl1a患者を選択する方法、システム、およびデバイス
|
CA3144267A1
(fr)
|
2019-06-21 |
2020-12-24 |
Entelexo Biotherapeutics Inc. |
Plateformes, compositions et methodes d'administration de composes therapeutiques
|
US11731962B2
(en)
|
2020-03-25 |
2023-08-22 |
Blacksmith Medicines, Inc. |
LpxC inhibitor and methods of making
|
US20210315902A1
(en)
*
|
2020-03-25 |
2021-10-14 |
Forge Therapeutics, Inc. |
Lpxc inhibitor, formulations, and uses thereof
|
WO2021245260A1
(fr)
*
|
2020-06-05 |
2021-12-09 |
Gregoriou Yiota |
Système de nanosupport thérapeutique et procédés d'utilisation
|
WO2022010537A1
(fr)
|
2020-07-10 |
2022-01-13 |
The Regents Of The University Of Michigan |
Inhibiteurs de gas41 et leurs méthodes d'utilisation
|
AU2021347140A1
(en)
*
|
2020-09-22 |
2023-06-01 |
Micronization Technologies And Therapeutics Group Llc |
Nebulizer and nebulized anti-virals
|
EP4263542A1
(fr)
|
2020-12-16 |
2023-10-25 |
Biomea Fusion, Inc. |
Composés de pyrimidine fusionnée utilisés comme inhibiteurs de l'interaction ménine-mll
|
US20230120115A1
(en)
|
2021-08-11 |
2023-04-20 |
Biomea Fusion, Inc. |
Covalent inhibitors of menin-mll interaction for diabetes mellitus
|
WO2023027966A1
(fr)
|
2021-08-24 |
2023-03-02 |
Biomea Fusion, Inc. |
Composés de pyrazine en tant qu'inhibiteurs irréversibles de flt3
|
WO2023039240A1
(fr)
|
2021-09-13 |
2023-03-16 |
Biomea Fusion, Inc. |
Inhibitors irréversibles de kras
|
WO2023086341A1
(fr)
|
2021-11-09 |
2023-05-19 |
Biomea Fusion, Inc. |
Inhibiteurs de kras
|
WO2023119230A1
(fr)
|
2021-12-22 |
2023-06-29 |
L'oreal |
Compositions de modulation de la voie de coagulation et de la voie de nicotinamide-adénine dinucléotide et leurs procédés d'utilisation
|
WO2023129667A1
(fr)
|
2021-12-30 |
2023-07-06 |
Biomea Fusion, Inc. |
Composés pyrazines utilisés comme inhibiteurs de flt3
|
WO2023235618A1
(fr)
|
2022-06-03 |
2023-12-07 |
Biomea Fusion, Inc. |
Composés de pyrimidine fusionnés en tant qu'inhibiteurs de la ménine
|
WO2024086613A2
(fr)
|
2022-10-19 |
2024-04-25 |
Myos Corp. |
Composés myogènes
|